Chronic kidney disease: Are elevated doses of ESAs associated with adverse outcomes?
Eckardt
Kai-Uwe
KU
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology*; D002908:Chronic Disease; D006397:Hematinics / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007674:Kidney Diseases / Q000150:complications* / Q000401:mortality; D012307:Risk Factors; D016896:Treatment Outcome
D006397:Hematinics